Zoekresultaten - 3 results
Annual Report Belgian Cystic Fibrosis Registry 2018
Pseudomonas aeruginosa reported in 2018 was 37.9%. This is in line with the general decline observed from 42.4% in 2012 to 37.5% in 2016. There has also been a steady increase in the prevalence of Achromobacter ...
Annual Report Belgian Cystic Fibrosis Registry 2017
2010 and 54.8% and 11.3% respectively among the children and adults in 2017. The overall annual prevalence of Pseudomonas aeruginosa reported in 2017 was 39.1%. This is the first time the prevalence has ...
Risk factors and impact of allergic bronchopulmonary aspergillosis in Pseudomonas aeruginosa-negative CF patients.
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a major complication in cystic fibrosis (CF) patients. Risk factors for ABPA and clinical deterioration in CF patients, negative for Pseudomonas ...